Advertisement
Advertisement

ANVS

ANVS logo

Annovis Bio, Inc.

2.28
USD
Sponsored
+0.02
+0.88%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

2.27

0.00
-0.22%

Annovis Bio, Inc. Profile

About

Annovis Bio Inc. is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease, Parkinson's disease and Alzheimer's in Down Syndrome. Annovis Bio Inc. is headquartered in Berwyn, Pennsylvania.

Info & Links

CEO

Maria Maccecchini

Headquarters

101 Lindenwood Drive, Suite 225
Malvern, PA 19355, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.annovisbio.com

Auditor

Ernst & Young LLP

Share holders

30

Employees

8

Annovis Bio, Inc. Statistics

Valuation Measures

Market Capitalization2

78.82M

Enterprise Value

59.29M

Enterprise Value/EBITDA(ttm)

-2.00

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.55

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-159.43%

Return on Invested Capital(ttm)

-170.52%

Return on Assets(ttm)

-133.49%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-29.70M

Net Income Available to Common(ttm)

-28.85M

Diluted EPS(ttm)

-1.40

Share Statistics

Beta (5Y Monthly)

1.37

52-Week Change

42.50%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

28.36M

Dividend Yield

0.00%

Float4

22.46M

% Held by Insiders

20.80%

% Held by Institutions

15.83%

Balance Sheet

Total Cash(mrq)

19.53M

Total Cash Per Share(mrq)

0.69

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.80%

Quick Ratio(mrq)

5.80%

Book Value Per Share(mrq)

0.62

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.25

Free Cash Flow(ytd)

-25.62M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement